Kelun-Biotech

Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical, is a clinical-stage biotech company engaged in biologic therapeutics as well as small molecule discovery and development.

ASCO
Favicon Fierce Pharma

At ASCO, China biotech industry cements its coming of age

Pfizer CEO Albert Bourla says he goes to bed and wakes up with two things in his mind: "China and AI."
Angus Liu Jun 3, 2026 8:50am
lung
Favicon Fierce Pharma

ASCO: Merck, Kelun's sac-TMT combo beats Keytruda by 65% on PFS

May 21, 2026 5:00pm
graphic image of different colored hands shaking

Crescent inks $80M Kelun deal, adding ADC to mix with bispecific

Dec 4, 2025 9:50am
Blue race track
Favicon Fierce Pharma

Merck grows more ambitious about 'workhorse' TROP2 ADC

Oct 20, 2025 4:00pm
windmill turbines in the Netherlands

Windward generates $200M with Novo Holdings, OrbiMed in tow

Jan 10, 2025 10:02am
change direction new plan alter arrows move reprioritize

Merck bags one Kelun ADC for $37.5M, boots out another asset

Aug 20, 2024 6:43am